D.E. Shaw & Co
TIL icon

D.E. Shaw & Co’s Instil Bio TIL Stock Holding History

D.E. Shaw & Co’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,808
Closed -$853K – 5122
2022
Q3 		$853K Sell
8,808
-3,968
-31% -$454K ﹤0.01% 3703
2022
Q2 		$1.18M Buy
12,776
+11,104
+664% +$1.57M ﹤0.01% 3513
2022
Q1 		$359K Buy
1,672
+1,141
+215% +$267K ﹤0.01% 4563
2021
Q4 		$182K Buy
+531
New +$205K ﹤0.01% 4915
2021
Q3 		– Sell
-2,123
Closed -$820K – 5237
2021
Q2 		$820K Buy
+2,123
New +$787K ﹤0.01% 3708

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's TIL Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 8,808 shares — an estimated $853K sold.

D.E. Shaw & Co first reported a position in TIL in Q2 2021 and held it in 5 quarters. The position peaked at $1.18M in Q2 2022. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 8,808 Instil Bio shares in Q4 2022, an estimated $853K.
  • D.E. Shaw & Co first reported a position in Instil Bio in Q2 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's Instil Bio position peaked at $1.18M in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.